Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Transplantation | 17 | 2024 | 332 | 5.490 |
Why?
|
Lung | 17 | 2025 | 1310 | 3.600 |
Why?
|
Organ Preservation | 7 | 2025 | 123 | 3.010 |
Why?
|
Perfusion | 13 | 2025 | 251 | 2.280 |
Why?
|
Glycocalyx | 2 | 2024 | 6 | 1.690 |
Why?
|
Glucuronidase | 2 | 2024 | 25 | 1.680 |
Why?
|
Reperfusion Injury | 3 | 2024 | 142 | 1.260 |
Why?
|
Primary Graft Dysfunction | 2 | 2024 | 41 | 1.110 |
Why?
|
Extracorporeal Membrane Oxygenation | 3 | 2024 | 198 | 1.070 |
Why?
|
Syndecan-1 | 2 | 2023 | 18 | 1.050 |
Why?
|
Extracorporeal Circulation | 3 | 2023 | 37 | 0.930 |
Why?
|
Hepatocytes | 1 | 2025 | 125 | 0.900 |
Why?
|
Organ Preservation Solutions | 2 | 2025 | 31 | 0.780 |
Why?
|
Graft Survival | 3 | 2024 | 918 | 0.780 |
Why?
|
Endothelial Cells | 1 | 2025 | 471 | 0.760 |
Why?
|
Tissue and Organ Procurement | 2 | 2023 | 365 | 0.760 |
Why?
|
Endothelium | 1 | 2021 | 60 | 0.740 |
Why?
|
Rats | 7 | 2023 | 4043 | 0.610 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 652 | 0.590 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 3303 | 0.590 |
Why?
|
Pyroptosis | 1 | 2017 | 5 | 0.590 |
Why?
|
Inflammation | 3 | 2023 | 998 | 0.540 |
Why?
|
Leukocytes | 1 | 2017 | 209 | 0.540 |
Why?
|
Protective Agents | 1 | 2014 | 34 | 0.460 |
Why?
|
Hydrogen | 1 | 2014 | 48 | 0.460 |
Why?
|
Postoperative Complications | 1 | 2024 | 2348 | 0.450 |
Why?
|
Reperfusion | 1 | 2014 | 32 | 0.440 |
Why?
|
Rats, Inbred Lew | 4 | 2020 | 197 | 0.440 |
Why?
|
Transplants | 1 | 2014 | 43 | 0.430 |
Why?
|
Oxygen | 1 | 2016 | 746 | 0.380 |
Why?
|
Cytokines | 5 | 2022 | 817 | 0.370 |
Why?
|
F-Box Proteins | 2 | 2022 | 14 | 0.360 |
Why?
|
Tissue Donors | 3 | 2023 | 516 | 0.350 |
Why?
|
Cardiopulmonary Bypass | 2 | 2023 | 160 | 0.330 |
Why?
|
Biomarkers | 3 | 2023 | 1814 | 0.320 |
Why?
|
Animals | 9 | 2024 | 27783 | 0.310 |
Why?
|
Lung Diseases | 2 | 2021 | 276 | 0.270 |
Why?
|
Male | 11 | 2024 | 43249 | 0.240 |
Why?
|
Receptor for Advanced Glycation End Products | 1 | 2025 | 19 | 0.240 |
Why?
|
Cell Hypoxia | 1 | 2025 | 174 | 0.230 |
Why?
|
Blood Group Incompatibility | 1 | 2023 | 22 | 0.220 |
Why?
|
Humans | 14 | 2025 | 91073 | 0.210 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2023 | 75 | 0.210 |
Why?
|
Retrospective Studies | 4 | 2024 | 9399 | 0.200 |
Why?
|
Intraoperative Care | 1 | 2023 | 85 | 0.200 |
Why?
|
Endothelium, Vascular | 1 | 2024 | 435 | 0.200 |
Why?
|
NF-kappa B | 1 | 2025 | 469 | 0.190 |
Why?
|
Graft Rejection | 2 | 2024 | 1091 | 0.190 |
Why?
|
Macrophages, Alveolar | 1 | 2021 | 62 | 0.180 |
Why?
|
Survival Rate | 1 | 2024 | 1898 | 0.170 |
Why?
|
Immunologic Memory | 1 | 2021 | 171 | 0.170 |
Why?
|
Cyclosporine | 1 | 2020 | 239 | 0.170 |
Why?
|
Cells, Cultured | 1 | 2025 | 2891 | 0.160 |
Why?
|
Mice, Knockout | 1 | 2024 | 2053 | 0.160 |
Why?
|
Benzylamines | 1 | 2018 | 17 | 0.160 |
Why?
|
Respiration, Artificial | 2 | 2020 | 361 | 0.150 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 453 | 0.150 |
Why?
|
Caspase 1 | 1 | 2017 | 20 | 0.150 |
Why?
|
Microcirculation | 1 | 2017 | 105 | 0.140 |
Why?
|
Follow-Up Studies | 1 | 2024 | 3716 | 0.140 |
Why?
|
Respiratory Function Tests | 1 | 2017 | 145 | 0.140 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 607 | 0.140 |
Why?
|
Immunohistochemistry | 1 | 2021 | 1806 | 0.140 |
Why?
|
Risk Factors | 2 | 2024 | 5608 | 0.140 |
Why?
|
Prognosis | 1 | 2024 | 3825 | 0.130 |
Why?
|
Pyridines | 1 | 2018 | 304 | 0.130 |
Why?
|
Interleukin-6 | 1 | 2017 | 268 | 0.130 |
Why?
|
Signal Transduction | 2 | 2025 | 3442 | 0.130 |
Why?
|
Models, Animal | 1 | 2016 | 278 | 0.120 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 988 | 0.120 |
Why?
|
Adult | 6 | 2024 | 27147 | 0.120 |
Why?
|
Transplantation, Isogeneic | 1 | 2014 | 40 | 0.120 |
Why?
|
Heme Oxygenase-1 | 1 | 2014 | 20 | 0.120 |
Why?
|
Lactic Acid | 1 | 2014 | 96 | 0.110 |
Why?
|
Middle Aged | 5 | 2024 | 26555 | 0.110 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2014 | 285 | 0.110 |
Why?
|
Mice | 2 | 2024 | 11993 | 0.110 |
Why?
|
Treatment Outcome | 3 | 2023 | 8436 | 0.100 |
Why?
|
Up-Regulation | 1 | 2014 | 727 | 0.100 |
Why?
|
Mitochondria | 1 | 2014 | 562 | 0.090 |
Why?
|
Female | 5 | 2024 | 47186 | 0.080 |
Why?
|
Warm Ischemia | 1 | 2023 | 32 | 0.050 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2022 | 8 | 0.050 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2023 | 86 | 0.050 |
Why?
|
Abatacept | 1 | 2022 | 86 | 0.050 |
Why?
|
Mice, Inbred DBA | 1 | 2022 | 150 | 0.050 |
Why?
|
Death | 1 | 2023 | 90 | 0.050 |
Why?
|
Glycoproteins | 1 | 2023 | 236 | 0.050 |
Why?
|
Brain Death | 1 | 2023 | 86 | 0.050 |
Why?
|
Allografts | 1 | 2022 | 192 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 175 | 0.050 |
Why?
|
Proteomics | 1 | 2023 | 242 | 0.050 |
Why?
|
Tissue Culture Techniques | 1 | 2021 | 81 | 0.050 |
Why?
|
Coculture Techniques | 1 | 2021 | 176 | 0.050 |
Why?
|
Deoxyadenine Nucleotides | 1 | 2020 | 3 | 0.050 |
Why?
|
Alarmins | 1 | 2020 | 6 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2022 | 1102 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 705 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 107 | 0.040 |
Why?
|
Transplantation Conditioning | 1 | 2020 | 378 | 0.040 |
Why?
|
Bioengineering | 1 | 2017 | 14 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2018 | 296 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2022 | 2033 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2021 | 1877 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2017 | 351 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 190 | 0.030 |
Why?
|
Calcium | 1 | 2020 | 1182 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2022 | 2416 | 0.030 |
Why?
|
Genetic Therapy | 1 | 2017 | 375 | 0.030 |
Why?
|
Time Factors | 1 | 2023 | 5378 | 0.030 |
Why?
|
Medical Oncology | 1 | 2017 | 390 | 0.030 |
Why?
|
United States | 1 | 2023 | 7188 | 0.020 |
Why?
|
Adolescent | 1 | 2018 | 9411 | 0.020 |
Why?
|
Aged | 1 | 2023 | 19574 | 0.020 |
Why?
|